Investigational new drug: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
An investigational new drug (IND) is a drug, antibiotic drug, or biological drug that is used in a clinical investigation. It also includes a biological product used in vitro for diagnostic purposes. | An investigational new drug (IND) is a drug, antibiotic drug, or biological drug that is used in a clinical investigation. It also includes a biological product used in vitro for diagnostic purposes. | ||
An IND filing with the [[FDA]] is required before starting [[clinical | An IND filing with the [[FDA]] is required before starting [[clinical trials]]. | ||
[[Category:Jargon]] | |||
Latest revision as of 18:04, 15 February 2014
An investigational new drug (IND) is a drug, antibiotic drug, or biological drug that is used in a clinical investigation. It also includes a biological product used in vitro for diagnostic purposes.
An IND filing with the FDA is required before starting clinical trials.